Alfaxan® consists of the active ingredient alfaxalone, a neurosteroid molecule with the properties of a general anaesthetic. Alfaxan® is presented as a clear, colourless, aqueous solution, with a pH of 6.5 – 7 in 10 mL or 20 mL vials. It is registered for use in dogs and cats for both the induction and maintenance of anaesthesia.
Australia’s number one anaesthetic induction agent, Alfaxan® produces rapid, controlled, and short-acting induction of anaesthesia in dogs and cats. With minimal impact on cardiac and pulmonary function, Alfaxan® has a wide safety margin and is rapidly cleared, resulting in smooth and clear-headed recovery.
|Dogs: 2 mg/kg||Dogs: 3 mg/kg|
|Cats: 5 mg/kg||Cats: 5 mg/kg|
|Dogs: 6-7 mg/kg/hr (0.10-0.12 mg/kg/minute)||Dogs: 8-9 mg/kg/hr (0.13-0.15 mg/kg/minute)|
|Cats: 7-8 mg/kg/hr (0.11-0.13 mg/kg/minute)||Cats: 10-11 mg/kg/hr (0.16-0.18 mg/kg/minute)|
Australia’s Animal Health Company